infohep news

• Coronavirus

  COVID-19 slows viral hepatitis elimination, global survey finds

  Keith Alcorn / 22 February 2021

  COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in laboratory capacity and telemedicine that will benefit future efforts to eliminate ...

• Coronavirus

  Hepatitis C does not raise the risk of death from COVID-19

  Keith Alcorn / 19 February 2021

  People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ...

• Diabetes & HCV

  Hepatitis C treatment reduces stroke and heart attack risk

  Keith Alcorn / 18 February 2021

  Hepatitis C treatment reduces the risk of subsequent stroke or heart attack by between 25 and 35%, a meta-analysis of studies published in the Journal of Viral Hepatitis shows. People with hepatitis C ...

• Injecting drug use

  Hepatitis C declining among drug users in UK

  Keith Alcorn / 11 February 2021

  The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since 2016, Public Health England reports. Around one in four ...

• Adherence to treatment

  High adherence and hepatitis C cure rates in active drug and alcohol users

  Keith Alcorn / 04 February 2021

  People who use drugs achieved high rates of hepatitis C cure on direct-acting antiviral treatment despite ongoing drug and alcohol use, demonstrating that active drug use should not be a barrier to ...